Peer mentoring for eating disorders: evaluation of a pilot program

Pilot and Feasibility Studies
Jennifer BeveridgeSteering group committee

Abstract

Eating disorders are serious psychiatric illnesses that are often associated with poor quality of life and low long-term recovery rates. Peer mentor programs have been found to improve psychiatric symptoms and quality of life in other mental illnesses, and a small number of studies have suggested that eating disorder patients may benefit from such programs. The aim of this study is to assess the efficacy of a peer mentor program for individuals with eating disorders in terms of improving symptomatology and quality of life. Up to 30 individuals with a past history of an eating disorder will be recruited to mentor 30 individuals with a current eating disorder. Mentoring will involve 13 sessions (held approximately every 2 weeks), of up to 3 h each, over 6 months. This pilot proof-of-concept feasibility study will inform the efficacy of a peer mentoring program on improving eating disorder symptomatology and quality of life, and will inform future randomised controlled trials. Australian and New Zealand Clinical Trials Registration Number: ACTRN12617001412325. The date of registration (retrospective): 05/10/2017.

References

Jan 1, 1989·The Journal of the American Academy of Psychoanalysis·E V BeresinD B Herzog
Nov 1, 1994·Psychological Medicine·D L BraunK A Halmi
Mar 1, 1996·Journal of Clinical Epidemiology·M Von KorffG E Simon
Oct 31, 1998·The Journal of Behavioral Health Services & Research·C T MowbrayM E Collins
Dec 16, 1998·The British Journal of Psychiatry : the Journal of Mental Science·E C Harris, B Barraclough
Sep 3, 1999·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·G HawthorneR Osborne
Jul 7, 2001·Community Mental Health Journal·L S CarlsonD McDiarmid
Jan 5, 2002·Psychiatric Rehabilitation Journal·S MeadL Curtis
Feb 28, 2002·Psychiatric Rehabilitation Journal·Mark S Salzer, Shoshanna Liptzin Shear
Aug 3, 2002·The American Journal of Psychiatry·Hans-Christoph Steinhausen
Apr 25, 2003·Behaviour Research and Therapy·Christopher G FairburnRoz Shafran
Feb 8, 2006·Schizophrenia Bulletin·Larry DavidsonMichael Rowe
Jun 23, 2006·The International Journal of Eating Disorders·Jennifer Couturier, James Lock
Dec 13, 2007·European Eating Disorders Review : the Journal of the Eating Disorders Association·Anita Federici, Allan S Kaplan
May 3, 2011·Psychiatric Services : a Journal of the American Psychiatric Association·William H SledgeLarry Davidson
Jul 21, 2011·Journal of Mental Health·Julie Repper, Tim Carter
Nov 3, 2012·Community Mental Health Journal·Galia S MoranCheryl Gagne
Mar 7, 2014·Qualitative Health Research·Lisa DawsonStephen Touyz
Nov 27, 2014·Journal of Eating Disorders·Marisol PerezShannon Cutts
Dec 15, 2016·Pilot and Feasibility Studies·Sandra M EldridgeUNKNOWN PAFS consensus group

❮ Previous
Next ❯

Citations

Jun 7, 2019·Journal of Eating Disorders·Jennifer BeveridgeDavid Castle

❮ Previous
Next ❯

Software Mentioned

Mentor
safeTALK

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.